Dec 27
|
Healthcare Stocks Had a Terrible 2023. Things Are Looking Up.
|
Dec 26
|
Sarepta (SRPT) Seeks Label Expansion for DMD Gene Therapy
|
Dec 23
|
Will Novo Nordisk Be Worth More Than Meta Platforms by 2030?
|
Dec 22
|
FDA warns Americans about fake Ozempic
|
Dec 22
|
Jazz Pharmaceuticals' (JAZZ) PTSD Drug Misses Study Goals
|
Dec 22
|
Fake Ozempic - FDA and Novo Nordisk Warn Against Counterfeit Ozempic Penetrating US Market Amid High Demand
|
Dec 22
|
Dow Jones Futures Fall As Nike Dives; Apple Leads Six Stocks To Watch With Inflation Data Due
|
Dec 21
|
UPDATE 2-US FDA warns about counterfeit versions of Novo's diabetes drug Ozempic
|
Dec 21
|
Universal Health (UHS) Up 17% in 3 Months: More Growth Ahead?
|
Dec 21
|
Merck's (MRK) Chronic Cough Drug Gets Another CRL From FDA
|
Dec 21
|
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
|
Dec 21
|
Looking to Invest in the Next Big Craze Like Ozempic? This 1 Emerging Field Could Be It.
|
Dec 21
|
Novo Nordisk A/S (NVO) Reported a Strong Third Quarter
|
Dec 20
|
Why Novo Nordisk Stock Was Up on a Down Day for the Market
|
Dec 20
|
FDA Accepts Merck's (MRK) BLA for 21-Valent Pneumococcal Jab
|
Dec 20
|
These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond
|
Dec 20
|
4 Drug Stocks Rising More Than 40% in 2023 With Room to Grow
|
Dec 19
|
Novo Nordisk Collaborates With India's Online Marketplace To Remove Unauthorized Wegovy Listings
|
Dec 19
|
Pfizer (PFE) Stock Rises on FDA Nod for Expanded Use of Padcev
|
Dec 19
|
Merck (MRK) Gets EU Nod for Expanded Use in Gastric Cancer
|